Bonus Presentations

Please note all sessions listed in Pacific Time. Agenda subject to change.
September
25
7:00 am
8:00 am
Non-CME/CE Bonus Presentation

Evidence-Based Treatment of Recurrent Pericarditis

Speaker: Amin Sabet, MD

Sponsored by Kiniksa Pharmaceuticals

September
25
11:00 am
11:45 am
Non-CME/CE Bonus Presentation

The History, the Present, the Future: Kevzara® (sarilumab) in RA, PMR and pJIA

Speaker: Ara Dikranian, MD

Sponsored by Sanofi

This program will highlight the critical role of IL-6 in the pathogenesis of a range of rheumatic diseases such as RA, PMR, and pJIA; review the efficacy data and safety profile over 10 years of studies; and explore the latest data on pJIA, the most recent indication.

September
25
12:50 pm
1:50 pm
Non-CME/CE Bonus Presentation

Changing Course: Clinical Evidence from the First Head-to-Head Trial Powered to Elevate the Superiority of Switching to a JAKi Versus Another TNFi After a Single TNFi Failure

Speaker: Bryan Gescuk, MD

Sponsored by AbbVie

September
26
7:00 am
8:00 am
Non-CME/CE Bonus Presentation

Autoantibodies in Myositis: From Pathogenesis to Investigational Targeted Approach With FcRn Blockade

Speaker: Prateek Gandiga, MD

Sponsored by argenx

Our expert faculty will highlight the underlying role of autoantibodies in myositis and explore how emerging treatment approaches may help address longstanding unmet needs in treatment management.

September
26
10:50 am
11:35 am
Non-CME/CE Bonus Presentation

Don't Wait, Treat With an Oral Non-Biologic: A Patient Case-Based Approach to Managing Psoriatic Arthritis

Speaker: Andrew J. Sulich, MD

Sponsored by Amgen

September
26
1:00 pm
2:00 pm
Non-CME/CE Bonus Presentation

Unveiling New Evidence in PsA Joint Efficacy: BE BOLD – A Head-to-Head Superiority Trial in PsA

Speaker: Sanjay Chabra, DO

Sponsored by UCB

Disclaimer: Bonus Presentations are independently organized and not an official part of the Perspectives in Rheumatic Diseases 2026 program. All presentations are non-CME/CE unless otherwise noted.